Stop Interfering! A Reflection on the Intrusive and Elusive Nature of Pain in Juvenile Idiopathic Arthritis

Tara R. McGrath,Dax G. Rumsey
DOI: https://doi.org/10.3899/jrheum.2024-0875
2024-11-02
The Journal of Rheumatology
Abstract:The face of juvenile idiopathic arthritis (JIA) management has transformed over the last 30 years, with advancements that have dramatically improved outcomes and overall prognosis. Yet, despite contemporary advances, including biologic therapies, pain in patients with JIA remains common.1 Pain has been reported as the most distressing manifestation of JIA.2 Why is it that we have come so far in JIA treatment but effective pain management for a subset of our patients with JIA remains elusive? The multifaceted and complex nature of pain in JIA makes it difficult to quantify and, therefore, difficult to study. Despite this, researchers in recent years have continued to work to determine the best way to measure, interpret, and understand pain in patients with JIA. Traditional pain measures that continue to be used in clinical settings have marked limitations. The 100-mm (or 10-cm) visual analog scale (VAS), which has been a foothold for both clinical and research measurement of pain intensity in patients with JIA, is the prototype of single-dimensional pain measurement tools. This simple horizontal line is anchored at each end: at the farthest left with "no pain" and at the farthest right with "worst pain imaginable." The VAS has been validated in pediatric populations and is used as both a self-reported and proxy-reported measure of pain intensity.3 This has been followed by numerous similar single-dimensional tools including various facial scales (eg, Oucher Scale, Wong-Baker FACES Pain Rating Scale, Faces Pain Scale), body outline figures (eg, body map), and other scales such as the Varni/Thompson Pediatric Pain Questionnaire that combine several instruments (VAS, body map, and a list of pain descriptors).4 Though these and similar adapted pain scales have been deemed adequate to measure pain intensity, a single measurement in a clinical setting is vastly insufficient at capturing the full ... Address correspondence to Dr. T.R. McGrath, Department of Pediatrics, Division of Rheumatology, University of Alberta, 3‐508 ECHA, 11405 87 Ave NW, Edmonton, AB T6G 1C9, Canada. Email: trm{at}ualberta.ca.
rheumatology
What problem does this paper attempt to address?